November 2020 FDA Recall Drug by Apotex Corp.
D-0106-2021 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Apotex Corp. on November 11, 2020 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0106-2021

Reason for Recall
Failed Dissolution Specifications: Out of specification for dissolution.
Initiated
11-11-2020
Reported
11-25-2020
Quantity
a)552 bottles; b) 3192 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Distributed Nationwide in the USA
Aripiprazole Tablets, USP 15 mg tablets, packaged in a) 1000 count bottle, NDC 60505-2675-8; b) 30 count bottle, NDC 60505-2675-3; Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326

Batch or Lot Expiration Information

Lot# a) PZ6716 Exp. 02/2021; b) PZ6715 Exp. 02/2021